In a study published in Cell Reports Physical Science on Nov. 25, a research team reported the development of an innovative ...

Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...

Ractigen's RAG-21, a treatment for ALS linked to mutations in the FUS gene, has been granted orphan drug designation in the U ...

Inspired by the way that squids use jets to propel themselves through the ocean and shoot ink clouds, researchers from MIT ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...

In a study published in Cell Reports Physical Science on Nov. 25, a research team led by Prof. CAI Lintao from the Shenzhen Institutes of Advanced ...

The MiDe systems, inspired by squid propulsion, demonstrate effective needle-free drug delivery in the gastrointestinal tract ...

The firm, which made no change to its Outperform rating or $200 price target, says the deal grants access to a very promising and competitive siRNA platform in terms of drug modality, target, and ...

2024年11月19日，中美瑞康（Ractigen Therapeutics）宣布其自主研发的FUS基因靶向小干扰RNA（siRNA）疗法RAG-21，成功获得美国食品药品监督管理局（FDA）授予的孤儿药资格（Orphan Drug ...

Inspired by the jets of water that squids use to propel themselves through the ocean, a team developed an ingestible capsule that releases a burst of drugs directly into the lining of the stomach or ...